Initial analysis of viral dynamics and circulating viral variants during the mRNA-1273 Phase 3 COVE trial.

Nat Med · 2022 · PMC9018421 · PMID 35145311

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

In our study, the findings that mRNA-1273 elicited a highly significant reduction in both viral copy number on the day of COVID-19 illness diagnosis and persistence of viral RNA in saliva samples indicative of viral shedding up to day 9 are relevant as potential surrogates for the transmissibility of the SARS-CoV-2 virus 3 , 5 , 12 .

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.